Edition:
United States

EyeGate Pharmaceuticals Inc (EYEG.OQ)

EYEG.OQ on NASDAQ Stock Exchange Capital Market

1.27USD
15 Dec 2017
Change (% chg)

$0.07 (+5.83%)
Prev Close
$1.20
Open
$1.20
Day's High
$1.29
Day's Low
$1.20
Volume
49,578
Avg. Vol
28,758
52-wk High
$3.89
52-wk Low
$0.90

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Paul Chaney

59 Chairman of the Board

Stephen From

54 2017 President, Director

Sarah Romano

2017 Interim Chief Financial Officer, Corporate Controller

Lisa Brandano

2017 Vice President - Clinical Operations

Michael Manzo

57 Vice President - Engineering